Bioventus Stock Analysis

Bioventus Stock Analysis Notes

About 66.0% of the company shares are held by institutions such as insurance companies. The book value of Bioventus was currently reported as 2.74. The company has Price/Earnings To Growth (PEG) ratio of 2.14. Bioventus recorded a loss per share of 1.54. The entity had not issued any dividends in recent years. Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the bodys natural healing process in the United States and internationally. The company was founded in 2011 and is headquartered in Durham, North Carolina. Bioventus Inc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1160 people. For more info on Bioventus please contact Kenneth Reali at 919 474 6700 or go to https://www.bioventus.com.

Bioventus Investment Alerts

Bioventus Upcoming and Recent Events

Bioventus Largest EPS Surprises

View All Earnings Estimates

Bioventus Thematic Classifications

Bioventus Stock Institutional Investors

Note, although Bioventus' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bioventus Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 295.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioventus's market, we take the total number of its shares issued and multiply it by Bioventus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bioventus Profitablity

The company has Net Profit Margin of (0.3) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.02 %, which entails that for every 100 dollars of revenue, it generated $0.02 of operating income.

Management Efficiency

Return On Tangible Assets is likely to gain to -0.46 in 2024. Return On Capital Employed is likely to drop to 0.02 in 2024. At this time, Bioventus' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 3.3 M in 2024, whereas Other Current Assets are likely to drop slightly above 12.7 M in 2024. Bioventus' management efficiency ratios could be used to measure how well Bioventus manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 19th of April, Bioventus shows the Risk Adjusted Performance of 0.0011, standard deviation of 3.49, and Mean Deviation of 2.67. Bioventus technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Bioventus, which can be compared to its peers. Please confirm Bioventus variance and potential upside to decide if Bioventus is priced correctly, providing market reflects its regular price of 4.55 per share. Given that Bioventus has information ratio of (0.03), we suggest you to validate Bioventus's prevailing market performance to make sure the company can sustain itself at a future point.

Bioventus Price Movement Analysis

Bioventus Insider Trading Activities

Bioventus Predictive Daily Indicators

Bioventus Corporate Filings

Bioventus Forecast Models

Bioventus' time-series forecasting models are one of many Bioventus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioventus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bioventus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bioventus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bioventus. By using and applying Bioventus Stock analysis, traders can create a robust methodology for identifying Bioventus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bioventus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bioventus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bioventus stock analysis indicators help investors evaluate how Bioventus stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bioventus shares will generate the highest return on investment. By understating and applying Bioventus stock analysis, traders can identify Bioventus position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioventus. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.

Is Bioventus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.